AZN

AstraZeneca PLC NYSE

Healthcare ·Drug Manufacturers - General ·GB · astrazeneca.com

$184.74

After hrs $182.05 -0.80%

Mkt Cap $144.3B

52w Low $132.32 65.2% of range 52w High $212.71

50d MA $196.94 200d MA $176.83

P/E (TTM) 14.0x

EV/EBITDA 8.1x

P/B 2.9x

Debt/Equity 0.6x

ROE —

P/FCF 11.6x

RSI (14) —

ATR (14) —

Beta 0.28

50d MA $196.94

200d MA $176.83

Avg Volume 2.2M

About

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Te…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 29, 2026	TNS	2.52	2.58	+2.4%	185.20	+1.8%	+1.2%	-0.2%	—	—	—	—	—
Feb 10, 2026	TNS	2.18	2.12	-2.8%	193.10	+3.6%	+6.0%	+5.9%	+6.4%	+8.5%	+8.1%	-0.3%	—
Nov 6, 2025	TNS	2.29	2.38	+3.9%	169.00	+0.3%	-1.7%	+3.5%	+3.7%	+3.9%	+5.0%	+7.1%	—
Jul 29, 2025	TNS	2.16	2.18	+0.9%	150.48	+0.3%	+3.4%	-2.1%	-2.0%	-0.1%	-0.1%	+5.1%	—
Apr 29, 2025	TNS	2.25	2.48	+10.2%	144.94	+1.1%	+0.5%	-3.0%	+1.2%	+0.7%	-4.1%	-1.3%	—
Feb 6, 2025	TNS	2.07	2.10	+1.4%	151.50	-5.3%	-5.7%	-1.5%	-6.2%	-3.3%	-1.7%	+1.8%	—
Nov 12, 2024	TNS	2.04	2.08	+2.0%	128.41	+0.6%	+0.6%	+1.4%	-0.4%	-2.3%	-1.9%	+3.1%	—
Jul 25, 2024	TNS	1.97	1.98	+0.5%	155.48	+1.3%	+2.6%	+0.5%	+0.2%	+2.6%	+3.3%	+12.5%	—
Apr 25, 2024	TNS	1.91	2.06	+7.9%	146.05	+1.6%	-0.7%	+0.1%	+3.4%	+3.4%	+5.1%	+8.5%	—
Feb 8, 2024	TNS	1.46	1.46	+0.0%	125.00	-2.6%	-1.2%	-3.5%	-1.2%	-2.6%	-0.8%	+6.7%	—
Nov 9, 2023	TNS	0.84	1.74	+106.4%	126.87	+0.1%	-2.0%	-1.7%	-0.8%	-1.3%	-1.4%	-1.3%	—
Jul 28, 2023	TNS	0.99	2.16	+118.6%	140.84	-0.6%	+2.8%	+1.4%	-1.2%	-1.3%	-0.4%	-3.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 13	UBS	Upgrade	Neutral → Buy	—	$146.43	$146.50	+0.0%	+1.7%	+1.6%	+1.0%	-1.1%	-0.6%
Nov 20	UBS	Upgrade	Sell → Neutral	—	$126.02	$126.58	+0.4%	-1.0%	+0.0%	+6.3%	+4.3%	+4.2%
Sep 11	Erste Group	Upgrade	Hold → Buy	—	$160.24	$160.92	+0.4%	+0.5%	-2.4%	-1.3%	-2.0%	-1.5%
Aug 12	TD Cowen	Maintains	Buy → Buy	—	$162.38	$160.71	-1.0%	-1.0%	+0.7%	+2.2%	+2.8%	+4.6%
May 30	Argus	Maintains	Buy → Buy	—	$146.20	$153.24	+4.8%	+5.0%	+5.2%	+8.4%	+6.9%	+9.5%
Apr 26	BMO Capital	Maintains	Outperform → Outperform	—	$146.05	$148.32	+1.6%	-0.7%	+0.1%	+3.4%	+3.4%	+5.1%
Apr 16	Deutsche Bank	Upgrade	Sell → Hold	—	$135.94	$138.80	+2.1%	-0.5%	+3.1%	+1.7%	+0.2%	+2.1%
Feb 12	BMO Capital	Maintains	Outperform → Outperform	—	$123.50	$122.80	-0.6%	-2.3%	+0.0%	-1.4%	+0.4%	+3.1%
Feb 8	Deutsche Bank	Downgrade	Buy → Hold	—	$133.34	$122.00	-8.5%	-6.3%	-7.4%	-9.5%	-7.4%	-8.7%
Jan 3	Jefferies	Downgrade	Buy → Hold	—	$132.81	$138.84	+4.5%	+4.3%	+3.2%	+2.1%	+5.0%	+5.1%
Sep 25	Jefferies	Upgrade	Hold → Buy	—	$137.93	$131.95	-4.3%	-0.7%	-2.2%	-3.5%	-1.3%	-2.1%
Sep 8	Erste Group	Downgrade	Buy → Hold	—	$134.68	$135.84	+0.9%	+0.8%	-1.1%	-1.8%	-3.4%	-1.2%
Aug 1	BMO Capital	Maintains	Outperform → Outperform	—	$144.82	$139.00	-4.0%	-1.4%	-3.9%	-4.0%	-3.2%	-2.4%
May 26	Argus	Maintains	Buy → Buy	—	$145.26	$144.58	-0.5%	-0.5%	-2.8%	+0.6%	+1.7%	+1.3%
Apr 13	Argus	Maintains	Buy → Buy	—	$147.25	$147.25	+0.0%	+1.6%	-0.8%	-0.3%	+1.1%	+0.4%
Nov 14	SVB Leerink	Maintains	Outperform → Outperform	—	$123.85	$128.98	+4.1%	+2.1%	+1.7%	+1.9%	+2.1%	+3.3%
Nov 11	SVB Leerink	Maintains	Outperform → Outperform	—	$127.28	$129.47	+1.7%	-2.7%	-0.7%	-1.1%	-0.8%	-0.6%
Aug 29	Argus	Upgrade	Hold → Buy	—	$131.44	$126.25	-3.9%	-2.0%	-4.3%	-5.3%	-10.2%	-3.7%
May 4	SVB Leerink	Maintains	Outperform → Outperform	—	$130.08	$134.32	+3.3%	-0.6%	-1.9%	-3.5%	-6.6%	-4.9%
Feb 24	SVB Leerink	Maintains	Outperform → Outperform	—	$121.42	$112.25	-7.6%	-5.2%	-0.1%	-3.5%	+0.5%	+2.9%
Feb 11	DZ Bank	Upgrade	Sell → Hold	—	$115.75	$116.82	+0.9%	-1.4%	-3.8%	+1.2%	+4.4%	+5.7%
Dec 7	Jefferies	Downgrade	Buy → Hold	—	$110.93	$111.39	+0.4%	-2.1%	+1.4%	-1.5%	-0.5%	-3.3%
Sep 27	SVB Leerink	Maintains	Outperform → Outperform	—	$122.30	$118.90	-2.8%	-4.0%	-4.8%	-2.9%	-0.6%	-3.7%
Sep 20	SVB Leerink	Maintains	Outperform → Outperform	—	$111.92	$112.00	+0.1%	+3.0%	+6.6%	+4.4%	+6.5%	+9.3%
Aug 4	SVB Leerink	Maintains	Outperform → Outperform	—	$115.49	$120.30	+4.2%	+0.9%	-0.4%	-1.4%	-2.9%	-1.4%
Jul 16	SVB Leerink	Maintains	Outperform → Outperform	—	$116.12	$115.26	-0.7%	-0.5%	-3.5%	+0.1%	-0.9%	+0.9%
Jun 4	SVB Leerink	Maintains	Outperform → Outperform	—	$112.00	$113.75	+1.6%	+1.7%	+0.4%	+1.6%	+1.8%	+4.5%
Apr 12	Argus	Downgrade	Buy → Hold	—	$101.34	$99.45	-1.9%	-2.0%	-2.1%	-2.3%	+0.7%	-0.8%
Mar 16	Jefferies	Upgrade	Hold → Buy	—	$97.00	$98.05	+1.1%	+1.6%	+3.8%	+3.6%	+2.7%	+4.6%
Mar 2	SVB Leerink	Maintains	Outperform → Outperform	—	$97.92	$96.10	-1.9%	-0.5%	-2.3%	-3.3%	-1.5%	-0.8%
Feb 25	UBS	Upgrade	Neutral → Buy	—	$98.90	$98.00	-0.9%	-2.6%	-1.6%	-1.0%	-1.5%	-3.3%
Dec 7	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$106.04	$106.05	+0.0%	+2.1%	+2.9%	+1.9%	+1.7%	+2.6%
May 29	SVB Leerink	Maintains	Outperform → Outperform	—	$108.00	$109.30	+1.2%	-0.7%	+0.0%	+0.7%	+0.6%	+1.1%
May 6	Argus	Maintains	Buy → Buy	—	$106.94	$110.71	+3.5%	+3.6%	-3.2%	-0.3%	+1.1%	+1.2%
Dec 2	Cowen & Co.	Maintains	Outperform → Outperform	—	$97.00	$97.34	+0.4%	-0.2%	-2.3%	-0.9%	-1.8%	-1.7%
Apr 2	UBS	Downgrade	Neutral → Sell	—	$80.40	$81.50	+1.4%	+0.2%	-0.1%	-0.9%	-1.3%	+1.6%
Apr 1	Cowen & Co.	Upgrade	Market Perform → Outperform	—	$80.86	$80.40	-0.6%	-0.6%	-0.3%	-0.7%	-1.5%	-1.9%
Nov 19	Investec	Downgrade	Buy → Hold	—	$81.34	$79.53	-2.2%	-1.3%	-0.8%	-1.1%	-1.2%	-1.4%
Aug 16	Jefferies	Downgrade	Buy → Hold	—	$76.90	$76.66	-0.3%	-1.3%	-0.9%	+1.0%	+0.7%	+0.9%
May 5	Argus	Upgrade	Hold → Buy	—	—	—	—	—	—	—	—	—
Mar 19	Jefferies	Upgrade	Hold → Buy	—	$69.18	$69.66	+0.7%	-0.1%	+0.5%	+1.2%	-0.3%	-1.2%
Feb 6	Leerink Swann	Maintains	Market Perform → Market Perform	—	$67.80	$66.70	-1.6%	+1.2%	+0.0%	+0.6%	-0.9%	+0.6%
Dec 29	JP Morgan	Upgrade	Neutral → Overweight	—	$68.22	$69.54	+1.9%	+1.7%	+0.5%	+3.9%	+1.9%	+2.4%
Oct 23	Leerink Swann	Maintains	Market Perform → Market Perform	—	$69.24	$69.14	-0.1%	-0.7%	-1.2%	-1.4%	-3.1%	-3.3%
Sep 22	Bernstein	Upgrade	Market Perform → Outperform	—	$64.00	$67.60	+5.6%	+6.1%	+3.0%	+1.3%	+4.1%	+4.6%
Sep 14	Liberum	Downgrade	Buy → Hold	—	$65.30	$65.06	-0.4%	-0.1%	-0.4%	-3.8%	+0.1%	+0.9%
Jul 28	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$58.53	$59.10	+1.0%	+1.7%	+2.9%	+2.2%	+2.9%	+1.0%
Jul 27	Leerink Swann	Downgrade	Outperform → Market Perform	—	$67.30	$57.10	-15.2%	-13.0%	-11.5%	-10.5%	-11.1%	-10.5%
May 15	Credit Suisse	Upgrade	Underperform → Neutral	—	$66.64	$67.94	+2.0%	+2.7%	+3.3%	+0.8%	+0.0%	+1.7%
Dec 9	Leerink Swann	Upgrade	Market Perform → Outperform	—	$52.54	$53.35	+1.5%	+3.6%	+2.6%	+2.5%	+3.9%	+2.5%

Data updated apr 24, 2026 8:19pm · Source: massive.com